QuidelOrtho Corp
QDEL28.135USD
+1.555+5.85%
收盤 11/25, 16:00（美東）報價延遲15分鐘
1.91B總市值
虧損本益比TTM
關於 QuidelOrtho Corp 公司
QuidelOrtho Corporation 從事體外診斷、開發和製造智能解決方案。該公司通過直銷團隊和分銷商網絡將其產品直接銷售給最終用戶，供醫生辦公室、醫院、臨牀實驗室、參考實驗室、緊急護理診所、大學、零售診所、藥房、健康篩查中心、其他即時診斷 (POC) 場所、血庫和捐獻中心的專業使用，以及供個人、非專業、非處方 (OTC) 使用。該公司以各種品牌提供診斷測試解決方案，包括 AdenoPlus、BIOVUE、FreshCells、InflammaDry、Lyra、MeterPro、MicroVue、Ortho、Ortho Clinical Diagnostics、Ortho Connect、Ortho Plus、Ortho Vision、QuickVue、Quidel、QuidelOrtho、QVue、Savanna、Sofia、Solana、Thyretain、Triage、Virena、Vitros 等。它爲 130 多個國家和地區的客戶提供支持。
QuidelOrtho Corp簡介
公司代碼QDEL
公司名稱QuidelOrtho Corp
上市日期Feb 01, 1991
CEOMr. Brian J. Blaser
員工數量6600
證券類型Ordinary Share
年結日Feb 01
公司地址9975 Summers Ridge Road
城市SAN DIEGO
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編92121
電話18585521100
網址https://www.quidelortho.com/
公司代碼QDEL
上市日期Feb 01, 1991
CEOMr. Brian J. Blaser
QuidelOrtho Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
104.41K
+9.68%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
72.55K
+7.29%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
33.58K
+75.18%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
32.03K
+8.95%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
21.35K
+35.98%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
14.27K
+75.49%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
11.45K
--
Mr. John R. Chiminski
Mr. John R. Chiminski
Independent Director
Independent Director
2.52K
--
Sergio Gadaleta
Sergio Gadaleta
Senior Vice President - Clinical and Regulatory Affairs
Senior Vice President - Clinical and Regulatory Affairs
--
--
Devon Burek
Devon Burek
Senior Vice President - Global Quality
Senior Vice President - Global Quality
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
104.41K
+9.68%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
72.55K
+7.29%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
33.58K
+75.18%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
32.03K
+8.95%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
21.35K
+35.98%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
14.27K
+75.49%
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Labs
369.70M
60.22%
Immunohematology
132.30M
21.55%
Point-of-Care
93.00M
15.15%
Donor Screening
13.30M
2.17%
Molecular Diagnostic Solutions
5.60M
0.91%
地區USD
名稱
營收
佔比
North America
310.70M
50.61%
Other
132.50M
21.58%
EMEA
87.30M
14.22%
China
83.40M
13.59%
業務
地區
業務USD
名稱
營收
佔比
Labs
369.70M
60.22%
Immunohematology
132.30M
21.55%
Point-of-Care
93.00M
15.15%
Donor Screening
13.30M
2.17%
Molecular Diagnostic Solutions
5.60M
0.91%
股東統計
更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
T. Rowe Price Investment Management, Inc.
16.21%
BlackRock Institutional Trust Company, N.A.
13.72%
The Vanguard Group, Inc.
11.19%
Rubric Capital Management LP
6.83%
Fidelity Management & Research Company LLC
6.54%
其他
45.52%
持股股東
持股股東
佔比
T. Rowe Price Investment Management, Inc.
16.21%
BlackRock Institutional Trust Company, N.A.
13.72%
The Vanguard Group, Inc.
11.19%
Rubric Capital Management LP
6.83%
Fidelity Management & Research Company LLC
6.54%
其他
45.52%
股東類型
持股股東
佔比
Investment Advisor
67.88%
Investment Advisor/Hedge Fund
35.55%
Hedge Fund
14.73%
Research Firm
2.25%
Pension Fund
1.07%
Individual Investor
0.94%
Private Equity
0.76%
Bank and Trust
0.61%
Sovereign Wealth Fund
0.52%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
656
79.44M
116.95%
-23.17M
2025Q2
684
78.51M
115.63%
-21.42M
2025Q1
726
76.59M
113.26%
-21.60M
2024Q4
747
75.07M
111.30%
-13.02M
2024Q3
744
73.58M
109.44%
-4.02M
2024Q2
767
70.18M
104.79%
-7.57M
2024Q1
799
67.05M
100.24%
-5.28M
2023Q4
828
68.21M
102.09%
-2.95M
2023Q3
842
70.19M
105.17%
-4.01M
2023Q2
860
68.99M
103.61%
-6.94M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
T. Rowe Price Investment Management, Inc.
11.14M
16.4%
-310.96K
-2.72%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.28M
13.67%
+1.73M
+22.86%
Jun 30, 2025
The Vanguard Group, Inc.
7.77M
11.44%
+1.04M
+15.55%
Jun 30, 2025
Rubric Capital Management LP
4.64M
6.83%
-1.50M
-24.47%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.56M
3.76%
+1.30M
+103.23%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.51M
3.69%
+691.35K
+38.04%
Jun 30, 2025
Newtyn Management, LLC
1.71M
2.51%
+490.67K
+40.38%
Jun 30, 2025
State Street Investment Management (US)
2.70M
3.98%
+510.29K
+23.29%
Jun 30, 2025
Invesco Advisers, Inc.
1.33M
1.96%
-2.27M
-63.07%
Jun 30, 2025
American Century Investment Management, Inc.
1.92M
2.82%
+327.00K
+20.58%
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
SPDR S&P Health Care Equipment ETF
1.75%
Invesco S&P SmallCap Health Care ETF
1.27%
Ballast Small/Mid Cap ETF
1.05%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.61%
JPMorgan Fundamental Data Science Small Core ETF
0.38%
SPDR S&P 600 Small Cap Value ETF
0.28%
iShares S&P Small-Cap 600 Value ETF
0.28%
Avantis US Small Cap Value ETF
0.28%
iShares U.S. Medical Devices ETF
0.24%
Invesco S&P SmallCap 600 Revenue ETF
0.22%
查看更多
SPDR S&P Health Care Equipment ETF
佔比1.75%
Invesco S&P SmallCap Health Care ETF
佔比1.27%
Ballast Small/Mid Cap ETF
佔比1.05%
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比0.61%
JPMorgan Fundamental Data Science Small Core ETF
佔比0.38%
SPDR S&P 600 Small Cap Value ETF
佔比0.28%
iShares S&P Small-Cap 600 Value ETF
佔比0.28%
Avantis US Small Cap Value ETF
佔比0.28%
iShares U.S. Medical Devices ETF
佔比0.24%
Invesco S&P SmallCap 600 Revenue ETF
佔比0.22%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
QuidelOrtho Corp的前五大股東是誰？
QuidelOrtho Corp的前五大股東如下：
T. Rowe Price Investment Management, Inc.持有股份：11.14M佔總股份比例：16.40%。
BlackRock Institutional Trust Company, N.A.持有股份：9.28M佔總股份比例：13.67%。
The Vanguard Group, Inc.持有股份：7.77M佔總股份比例：11.44%。
Rubric Capital Management LP持有股份：4.64M佔總股份比例：6.83%。
Fidelity Management & Research Company LLC持有股份：2.56M佔總股份比例：3.76%。
T. Rowe Price Investment Management, Inc.持有股份：11.14M佔總股份比例：16.40%。
BlackRock Institutional Trust Company, N.A.持有股份：9.28M佔總股份比例：13.67%。
The Vanguard Group, Inc.持有股份：7.77M佔總股份比例：11.44%。
Rubric Capital Management LP持有股份：4.64M佔總股份比例：6.83%。
Fidelity Management & Research Company LLC持有股份：2.56M佔總股份比例：3.76%。
QuidelOrtho Corp的前三大股東類型是什麼？
QuidelOrtho Corp 的前三大股東類型分別是：
T. Rowe Price Investment Management, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Investment Management, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
有多少機構持有QuidelOrtho Corp(QDEL)的股份？
截至2025Q3，共有656家機構持有QuidelOrtho Corp的股份，合計持有的股份價值約為79.44M，占公司總股份的116.95% 。與2025Q2相比，機構持股有所增加，增幅為1.32%。
哪個業務部門對QuidelOrtho Corp的收入貢獻最大？
在FY2025Q2，Labs業務部門對QuidelOrtho Corp的收入貢獻最大，創收369.70M，占總收入的60.22% 。
